Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 10;17:4725–4741. doi: 10.2147/IJN.S381170

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Chen et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The antitumor effect of M1/IR780@PLGA nanoparticles. (A) Schematic illustration of the time schedule for in vivo treatment of tumor-bearing mice. (B) The photographs of tumor-bearing mice before and after different treatments at 7, 14 and 21 days. (C) Tumor growth curve and (D) average tumor weight of mice after different treatments. Data are expressed as means SD (n = 5). Statistical significances were calculated via one-way ANOVA, *P < 0.05, ***P < 0.001. (E) H&E staining of tumor tissue slices after different treatments, scale bar = 100 μm.